EUVIMEDEUVIMED entdecken
Crossref

69 | ESCAPE FROM CAR‐NEGATIVE ENDOGENOUS CD8 T CELLS DRIVES RESISTANCE TO CD19‐DIRECTED CAR‐T THERAPIES IN LARGE B‐CELL LYMPHOMAS

B. Ziccheddu, V. V. Saralamma, M. D. Jain, C. Savid‐Frontera, A. D. Newsam, C. Gatenbee, M. Chojnacka, M. Durante, O. Landgren, A. R. Anderson, F. Maura, J. H. Schatz und 1 weitere

Hematological Oncology · 2025-06 · 43 (S3)

DOI: 10.1002/hon.70093_69 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematological Oncology, online erschienen am 16.06.2025. Verfasst von B. Ziccheddu und 12 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ziccheddu, B., Saralamma, V. V., Jain, M. D., Savid‐Frontera, C., Newsam, A. D., Gatenbee, C., Chojnacka, M., Durante, M., Landgren, O., Anderson, A. R., Maura, F., Schatz, J. H., & Locke, F. L. (2025). 69 | ESCAPE FROM CAR‐NEGATIVE ENDOGENOUS CD8 T CELLS DRIVES RESISTANCE TO CD19‐DIRECTED CAR‐T THERAPIES IN LARGE B‐CELL LYMPHOMAS. Hematological Oncology, 43(S3). https://doi.org/10.1002/hon.70093_69

Vancouver

Ziccheddu B, Saralamma VV, Jain MD, Savid‐Frontera C, Newsam AD, Gatenbee C, et al. 69 | ESCAPE FROM CAR‐NEGATIVE ENDOGENOUS CD8 T CELLS DRIVES RESISTANCE TO CD19‐DIRECTED CAR‐T THERAPIES IN LARGE B‐CELL LYMPHOMAS. Hematological Oncology. 2025;43(S3). doi:10.1002/hon.70093_69

BibTeX
@article{Ziccheddu2025,
  author = {Ziccheddu, B. and Saralamma, V. V. and Jain, M. D. and Savid‐Frontera, C. and Newsam, A. D. and Gatenbee, C. and Chojnacka, M. and Durante, M. and Landgren, O. and Anderson, A. R. and Maura, F. and Schatz, J. H. and Locke, F. L.},
  title = {69 | ESCAPE FROM CAR‐NEGATIVE ENDOGENOUS CD8 T CELLS DRIVES RESISTANCE TO CD19‐DIRECTED CAR‐T THERAPIES IN LARGE B‐CELL LYMPHOMAS},
  journal = {Hematological Oncology},
  year = {2025},
  volume = {43},
  number = {S3},
  doi = {10.1002/hon.70093_69}
}
Kostenlos starten →